Lindor K - Search Results

1

Machine learning in primary biliary cholangitis: A novel approach for risk stratification.

Gerussi A, Verda D, Bernasconi DP, Carbone M, Komori A, Abe M, Inao M, Namisaki T, Mochida S, Yoshiji H, Hirschfield G, Lindor K, Pares A, Corpechot C, Cazzagon N, Floreani A, Marzioni M, Alvaro D, Vespasiani-Gentilucci U, Cristoferi L, Valsecchi MG, Muselli M, Hansen BE, Tanaka A, Invernizzi P. Gerussi A, et al. Among authors: lindor k. Liver Int. 2022 Mar;42(3):615-627. doi: 10.1111/liv.15141. Epub 2022 Jan 7. Liver Int. 2022. PMID: 34951722

2

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

Crippin JS, Lindor KD, Jorgensen R, Kottke BA, Harrison JM, Murtaugh PA, Dickson ER. Crippin JS, et al. Among authors: lindor kd. Hepatology. 1992 May;15(5):858-62. doi: 10.1002/hep.1840150518. Hepatology. 1992. PMID: 1568727 Clinical Trial.

3

Recent advances in the management of primary sclerosing cholangitis.

Lindor KD, Wiesner RH, LaRusso NF. Lindor KD, et al. Semin Liver Dis. 1987 Nov;7(4):322-7. doi: 10.1055/s-2008-1040588. Semin Liver Dis. 1987. PMID: 3324352 Review. No abstract available.

4

Primary biliary cirrhosis.

Laurin JM, Lindor KD. Laurin JM, et al. Among authors: lindor kd. Dig Dis. 1994 Nov-Dec;12(6):331-50. doi: 10.1159/000171469. Dig Dis. 1994. PMID: 7712616 Review.

5

Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER. Lindor KD, et al. Hepatology. 1995 Feb;21(2):389-92. Hepatology. 1995. PMID: 7843710 Clinical Trial.

6

Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.

Balan V, Dickson ER, Jorgensen RA, Lindor KD. Balan V, et al. Among authors: lindor kd. Mayo Clin Proc. 1994 Oct;69(10):923-9. doi: 10.1016/s0025-6196(12)61815-1. Mayo Clin Proc. 1994. PMID: 7934188 Clinical Trial.

7

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.

Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, et al. Lindor KD, et al. Gastroenterology. 1994 May;106(5):1284-90. doi: 10.1016/0016-5085(94)90021-3. Gastroenterology. 1994. PMID: 8174890 Clinical Trial.

8

Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis.

Lindor KD. Lindor KD. Semin Liver Dis. 1993 Nov;13(4):367-73. doi: 10.1055/s-2007-1007365. Semin Liver Dis. 1993. PMID: 8303318 Review.

9

Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.

Batts KP, Jorgensen RA, Dickson ER, Lindor KD. Batts KP, et al. Among authors: lindor kd. Am J Gastroenterol. 1996 Nov;91(11):2314-7. Am J Gastroenterol. 1996. PMID: 8931409 Clinical Trial.

10

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.

Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, Krom RA, Wiesner RH, Lindor KD. Kim WR, et al. Among authors: lindor kd. Hepatology. 1997 Jul;26(1):22-6. doi: 10.1002/hep.510260103. Hepatology. 1997. PMID: 9214447 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

481 results

Search Page

Filters